CLINICAL_TRIALS
ClinicalTrials.gov record update
Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07221292
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:08.017716+00:00
- Published At
- 2026-03-27T00:00:00+00:00
- Record Updated At
- 2026-03-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["CACNA1A", "Spinocerebellar Ataxia Type 6", "Episodic Ataxia Type 2", "Familial Hemiplegic Migraine-1"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-27"- protocolSection.identificationModule.nctId
"NCT07221292"- protocolSection.identificationModule.officialTitle
"Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.